KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to 22.35%.

  • Organon's EBITDA Margin fell 23100.0% to 22.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.19%, marking a year-over-year increase of 228100.0%. This contributed to the annual value of 2.64% for FY2024, which is 3900.0% up from last year.
  • Per Organon's latest filing, its EBITDA Margin stood at 22.35% for Q3 2025, which was down 23100.0% from 20.33% recorded in Q2 2025.
  • Organon's 5-year EBITDA Margin high stood at 24.65% for Q3 2024, and its period low was 36.23% during Q4 2023.
  • Moreover, its 5-year median value for EBITDA Margin was 13.75% (2021), whereas its average is 7.86%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first tumbled by -254200bps in 2021, then surged by 596800bps in 2024.
  • Over the past 5 years, Organon's EBITDA Margin (Quarter) stood at 22.65% in 2021, then crashed by -44bps to 32.53% in 2022, then fell by -11bps to 36.23% in 2023, then skyrocketed by 150bps to 18.09% in 2024, then grew by 24bps to 22.35% in 2025.
  • Its EBITDA Margin stands at 22.35% for Q3 2025, versus 20.33% for Q2 2025 and 15.8% for Q1 2025.